Financhill
Back

PROCEPT BioRobotics Quote, Financials, Valuation and Earnings

PROCEPT BioRobotics Price Quote

$94.28
-0.17 (1.7%)
(Updated: November 22, 2024 at 5:41 AM ET)

PROCEPT BioRobotics Key Stats

Sell
43
PROCEPT BioRobotics (PRCT) is a Sell

Day range:
$92.45 - $95.36
52-week range:
$33.45 - $103.81
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
24.25
P/B ratio:
21.19%

Volume:
388.6K
Avg. volume:
1M
1-year change:
180.1%
Market cap:
$5.1B
Revenue:
$136.2M
EPS:
$-1.95

How Much Does PROCEPT BioRobotics Make?

Is PROCEPT BioRobotics Growing As A Company?

  • What Is PROCEPT BioRobotics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.66%
  • What Is PROCEPT BioRobotics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

PROCEPT BioRobotics Stock Price Performance

What Is PROCEPT BioRobotics 52-Week High & Low?

PROCEPT BioRobotics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PROCEPT BioRobotics?

Is PROCEPT BioRobotics Cash Flow Positive?

  • What Is PRCT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$91.6M
  • What Is PROCEPT BioRobotics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.5M
  • What Is PROCEPT BioRobotics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$12M

PROCEPT BioRobotics Return On Invested Capital

  • Is Management Doing A Good Job?
    PRCT return on invested capital is -31.39%
  • What Is PROCEPT BioRobotics Return On Assets?
    ROA measures how assets are converting to revenues and is -25.56%
  • What Is PRCT Return On Equity?
    ROE is a measure of profitability and is -37.42%

PROCEPT BioRobotics Earnings Date & Stock Price

PROCEPT BioRobotics Competitors

  • Who Are PROCEPT BioRobotics's Competitors?
    Below is a list of companies who compete with PROCEPT BioRobotics or are related in some way:
    • Boston Scientific Corp (BSX)
    • Perspective Therapeutics Inc (CATX)
    • Intuitive Surgical Inc (ISRG)
    • Teleflex Inc (TFX)
    • Xtant Medical Holdings Inc (XTNT)

PROCEPT BioRobotics Dividend Yield

PROCEPT BioRobotics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 18.09%
Revenue: 66.29% 9.75%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 101.00
Upside from Last Price: 6.93%

Major Shareholders

  • How many PRCT shares are owned by institutional investors?
    82.5M PRCT shares are owned by institutional investors
  • How many PRCT shares are owned by insiders?
    1.6M PRCT shares are owned by insiders